Skip to content

Clinical trials

Phase 2/3 Leukemia, Myeloid, Acute trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2/3 Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20162
20171
20186
20211
20222
20231
20242
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Recruiting6
Completed3
Enrolling by invitation3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University7
The First Affiliated Hospital of Soochow University7
First Affiliated Hospital of Zhejiang University2
Fujian Medical University1
Guangdong Second Provincial General Hospital1
Institute of Hematology & Blood Diseases Hospital, China1
Peking University People's Hospital1
Sichuan Baili Pharmaceutical Co., Ltd.1
The Second Affiliated Hospital of Kunming Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute22
Neoplasm, Residual3
Myelodysplastic Syndromes2
Frailty1
Hematologic Neoplasms1
Thrombocytopenia1
Wilms Tumor1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.